Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.05) by 220 percent. This is a 300 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $39.400 million which missed the analyst consensus estimate of $54.500 million by 27.71 percent. This is a 34.98 percent decrease over sales of $60.600 million the same period last year.